From its headquarters in Cambridge UK, Altacor is using its drug development skills and in depth market knowledge to build a portfolio of high quality, differentiated prescription medicines that set new standards in the sector.
Meet the Altacor team.
Altacor has three areas of therapeutic interest: Ocular Surface Disease including Dry Eye syndrome, Ocular Infection and Glaucoma
Partnerships with hospitals and academic departments as well as other pharmaceutical companies are an important component of Altacor’s growth.
Confidential information for investors will be available from this page.